Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Variable regions 1 and 2 (V1/V2) of human immunodeficiency virus-1 (HIV-1) gp120 envelope glycoprotein are critical for viral evasion of antibody neutralization, and are themselves protected by extraordinary sequence diversity and N-linked glycosylation. Human antibodies such as PG9 nonetheless engage V1/V2 and neutralize 80% of HIV-1 isolates. Here we report the structure of V1/V2 in complex with PG9. V1/V2 forms a four-stranded β-sheet domain, in which sequence diversity and glycosylation are largely segregated to strand-connecting loops. PG9 recognition involves electrostatic, sequence-independent and glycan interactions: the latter account for over half the interactive surface but are of sufficiently weak affinity to avoid autoreactivity. The structures of V1/V2-directed antibodies CH04 and PGT145 indicate that they share a common mode of glycan penetration by extended anionic loops. In addition to structurally defining V1/V2, the results thus identify a paradigm of antibody recognition for highly glycosylated antigens, which-with PG9-involves a site of vulnerability comprising just two glycans and a strand.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Sometimes, such protective glycosylation can become so dense that it generates unique clustered epitopes recognized by speci fi c antibodies, such as that seen on the surface of the HIV virion (507 -509, 594).”
From Biological roles of glycans (2017) · cites this paper as [507]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612 · cited 1×
“and a molecular replacement solution for the 1FD6-ZM109 data set consisting of two unbound PG9 Fab molecules per asymmetric unit was obtained using PHASE”
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 9,984
Nicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
The Anatomy and Taxonomy of Protein Structure
Richardson, J. S. (1981) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60520-3 · Cited by 3,375
Research works printed but not linked: 2
- Zolla-Pazner S V2-reactive antibodies in RV144 vaccinees’ plasma AIDS Res Hum Retroviruses 27 A-21 2011
- Otwinowski, Z. & Minor, W. in Methods Enzymol. Vol. 276, 307–326 (Academic Press, 1997)
Cited by
Items 801–831 of 831
Multiple Mechanisms of HIV-1 Resistance to PGT135 in a Chinese Subtype B’ Slow Progressor
Hu, Y., Sun, S., Liu, Y., Ren, L., Hu, X., Ruan, Y., Ma, L., Liang, H., Shao, Y., Hong, K., et al. (2025) · Pathogens · doi:10.3390/pathogens14060556
Marceau, T., Migraine, J., Moreau, A., Arrouche, Y., Andriantsoanirina, V., Verrier, B., Mammano, F., Meyer, L., & Braibant, M. (2025) · AIDS · doi:10.1097/qad.0000000000004304 · Cited by 1
Mechanisms for cross-neutralisation of diverse bat sarbecovirusesPreprint
Upadhyay, A., Seow, J., Alguel, Y., Newman, J., Thakur, N., Hay, A. L., Tam, J. C. H., Nans, A., Orton, R. J., Bailey, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.17.674891
Enhancing functional antibody responses against HIV envelope V1V2 through vaccine formulations
Yengo, C. K., Liu, X., Laghlali, G., Park, S., Klingler, J., Luo, C. C., Jiang, X., Kong, X., Rao, P. G., Upadhyay, C., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1722596
Wieczorek, L., Chang, D., Sanders‐Buell, E., Zemil, M., Martinez, E. J., Schoen, J., Chenine, A.-L., Molnar, S., Barrows, B. M., Poltavee, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26741396
Wieczorek, L., Chang, D., Sanders‐Buell, E., Zemil, M., Martinez, E. J., Schoen, J., Chenine, A.-L., Molnar, S., Barrows, B. M., Poltavee, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26741399
Wieczorek, L., Chang, D., Sanders‐Buell, E., Zemil, M., Martinez, E. J., Schoen, J., Chenine, A.-L., Molnar, S., Barrows, B. M., Poltavee, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26741390
Wieczorek, L., Chang, D., Sanders‐Buell, E., Zemil, M., Martinez, E. J., Schoen, J., Chenine, A.-L., Molnar, S., Barrows, B. M., Poltavee, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26741393
Conformational Variability of HIV-1 Env Trimer and Viral VulnerabilityPreprint
Cao, Y., & Im, W. (2026) · eLife · doi:10.7554/elife.110107.1
Early clonal dominance at priming sets the trajectory for broad HIV serum neutralizationPreprint
Liang, B., Zhu, Y., Roark, R. S., Li, X., Mishra, N., Martella, C. L., Vo, A. L., Giese, G., Huang, Q., Biju, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.04.709621
Self-citationChaillon, A. (2012) · theses.fr (ABES) · doi:10.70675/843c5a6az223az4fa8z9981za026693a5600
“Des résultats similaires ont été récemment rapportés avec les anticorps monoclonaux PG9 et PG16, confirmant le rôle prépondérant du squelette d’enveloppe et notamment de la boucle variable V1V2 dans la constitution/accessibilité à des épitopes glycopeptidiques complexes situés sur les glycoprotéines du VIH-1 (Doores e…”
InfluentialBenjelloun, F. (2013) · theses.fr (ABES) · doi:10.70675/3bf8d428z94b9z4ddaza841zdfaab92f44a3
“Le feuillet C est le plus variable de V1/V2, et cette liaison indépendante de la séquence signifie qu’elle permet probablement une augmentation de la reconnaissance [217].”
BackgroundInfluentialCharacterization of Hepatitis C Virus interaction with heparan sulfate proteoglycans
Xu, Y. (2014) · theses.fr (ABES) · doi:10.70675/b8c9dc27z15cfz4921zad5czee757d47d341
Tian, M., Cheng, H.-L., Davis, J., Thompson, L. M., Chapdelaine-Williams, A. M., Tuchel, M.-E., Yin, A., Hu, J., Lin, X., Ye, A. Y., et al. (2026) · eLife · doi:10.64898/2026.03.30.715354 · Cited by 1
Beretta, M. (2018) · theses.fr (ABES) · doi:10.70675/73879457zfc7az4e7ez9335z05a71fdf3d26 · Cited by 1
Rouzeau, R. (2021) · theses.fr (ABES) · doi:10.70675/e000e96az548ez4bd9zb7aczcb03c29fb57c · Cited by 1
Structural Insights Into Man 9 Recognition by the HIV Antibody 2G12 Revealed by Paramagnetic NMR
Silva-Díaz, A., Oquist-Phillips, P., de la Cruz, N., Lera‐Lasso, I., Castañar, L., Rojo, J., Ramos‐Soriano, J., & Canales, Á. (2026) · Advanced Science · doi:10.1002/advs.202600025
“Additionally, the Man 5 A structure is recognized by another glycan-targeting gp120 antibody PG9 [ 17 ].”
Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies
Tao, K., Herschhorn, A., Fera, D., Lynch, R. M., Jülg, B. D., Korber, B., & Shafer, R. W. (2026) · Communications Medicine · doi:10.1038/s43856-026-01680-w · Cited by 1
“They have an extraordinarilylongCDRH3,typically26to30aminoacidslong,thatallows penetrationoftheglycanshieldtoreachthecoreproteinepitope 174,175 .”
King, H. A. D., Subra, C., Tourtellott‐Fogt, E., Swafford, I., Basu, S., Rossman, M. J., Phillips, L., Obarorakpor, N., Ding, S., Ferrari, M. G., et al. (2026) · Journal of Virology · doi:10.1128/jvi.00389-26
“…(bNAbs) or non-neu tralizing (nNAbs) monoclonal antibodies known to target distinct Env conformations. bNAbs PG9 (trimer apex-specific) (67) and PGT151 (gp120:gp41 interface-specific) (68) preferentially bind Env in a closed conformation, whereas the nNAbs bind Env following transition…”
Physicochemical developability insights into human Fab fragments with extended hypervariable loops
Passon, M., Bandera, G., Mayerhöfer, L., Smedt, S. C. D., & Svilenov, H. L. (2026) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2026.104447
Engineering Protein-Based HIV Entry Inhibitors: Advances, Challenges, and Translational Strategies
Kumariya, R., & Bewley, C. A. (2026) · Biomolecules · doi:10.3390/biom16091221
Self-citationBA-ARAP-NMA: A Local Geometry Control Nonlinear Normal-Mode Analysis Method
Zhang, Z., Liu, D., Yu, H., & Luyan, Z. (2026) · Biology · doi:10.3390/biology15171533
Decoding Clade-Specific bNAb–HIV-1 Env Interactions Using Machine LearningPreprint
Kumar, Y., Lin, S., Dixit, N. M., & Maiti, P. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.14.759022
“53,86,100 PG9, a V1V2-apex bNAb that recognizes the glycan-dependent quaternary epitope centred on N160-gp120, 101 represents a notable outlier.”
Clinical immunogenicity assessment of HIV/AIDS vaccines: current progress and future perspectives
Yu, H., Wu, X., Li, T., & Nie, J. (2026) · Emerging Microbes & Infections · doi:10.1080/22221751.2026.2751675
“Located at the HIV-1 Env trimer apex, the highly variable V1V2 loops sterically shield underlying conserved epitopes [52].”
Advances in HIV-1 Envelope-Based Vaccine Development
Chan, K., Jiang, X., Wang, A. L., Kong, X.-P., & Wu, X. (2026) · Vaccines · doi:10.3390/vaccines14100914
“V1V2 bNAbs typically employ long, acidic CDR-H3 loops that project toward the trimer axis, penetrating between the V2 N160 glycan and adjacent glycans to engage conserved basic residues such as K169 on strand C of V2 [21–23].”
Metadata
- Authors
- McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J.-P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., O’Dell, S., Patel, N., Shahzad-ul-Hussan, S., Yang, Y., Zhang, B., Zhou, T., Zhu, J., Boyington, J. C., Chuang, G.-Y., Diwanji, D., Georgiev, I., Do Kwon, Y., Lee, D., Louder, M. K., Moquin, S., Schmidt, S. D., Yang, Z.-Y., Bonsignori, M., Crump, J. A., Kapiga, S. H., Sam, N. E., Haynes, B. F., Burton, D. R., Koff, W. C., Walker, L. M., Phogat, S., Wyatt, R., Orwenyo, J., Wang, L.-X., Arthos, J., Bewley, C. A., Mascola, J. R., Nabel, G. J., Schief, W. R., Ward, A. B., Wilson, I. A., & Kwong, P. D.
- Affiliations
- National Institutes of Health (US)
- University of Washington (US)
- Scripps Research Institute (US)
- Duke University (US)
- Tumaini University (TZ)
- International AIDS Vaccine Initiative (US)
- University of Maryland, Baltimore (US)
- Corresponding author
- Kwong, Peter D.
- ORCID
- McLellan, Jason S.
- Pancera, Marie
- Carrico, Chris
- Gorman, Jason
- Julien, Jean-Philippe
- Khayat, Reza
- Louder, Robert
- Patel, Nikita
- Yang, Yongping
- Zhang, Baoshan
- Zhou, Tongqing
- Zhu, Jiang
- Boyington, Jeffrey C.
- Chuang, Gwo-Yu
- Diwanji, Devan
- Georgiev, Ivelin
- Louder, Mark K.
- Moquin, Stephanie
- Schmidt, Stephen D.
- Bonsignori, Mattia
- Crump, John A.
- Kapiga, Saidi H.
- Haynes, Barton F.
- Burton, Dennis R.
- Koff, Wayne C.
- Walker, Laura M.
- Wyatt, Richard
- Wang, Lai-Xi
- Arthos, James
- Bewley, Carole A.
- Mascola, John R.
- Nabel, Gary J.
- Schief, William R.
- Ward, Andrew B.
- Wilson, Ian A.
- Kwong, Peter D.
- Venue
- Nature
- Published
- 2011-11-23
- Volume
- 480
- Issue
- 7377
- Pages
- 336-343
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3406929
- OpenAlex
- W2122617162
- Cited by
- 830
- References
- 69
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 23 · 2023: 25 · 2022: 36 · 2021: 38 · 2020: 39 · 2019: 52 · 2018: 63 · 2017: 70 · 2016: 64 · 2015: 84 · 2014: 92 · 2013: 120 · 2012: 78
- FWCI
- 36.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- U.S. Department of Energy (W - 31 - 109 - Eng - 38)
- International AIDS Vaccine Initiative
- Ragon Institute of MGH, MIT and Harvard
- National Institutes of Health
- Office of Science (W-31-109-ENG-38)
- Canadian Institutes of Health Research
- National Institute of Allergy and Infectious Diseases (R01AI033292, R01AI084817)
- National Center for Research Resources (RR017573, P41RR017573)
- Basic Energy Sciences (W-31-109-Eng38)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- HIV-1 gp120, antibody-antigen complex structure, N-glycosylation, carbohydrate recognition, HIV vaccine development, envelope glycoprotein
- MeSH terms
- Amino Acid Sequence, Antibody Affinity, Antibody Specificity, Antigen-Antibody Complex, Epitopes, Binding Sites, Antibody, Glycopeptides, Glycosylation, Hydrogen Bonding, Models, Molecular, Molecular Sequence Data, Polysaccharides, HIV Antibodies, HIV-1, HIV Envelope Protein gp120, AIDS Vaccines, Conserved Sequence, Protein Structure, Tertiary, Crystallography, X-Ray, Amino Acid Motifs, Protein Structure, Quaternary, Immune Evasion, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.